Download PDF
CC BY 4.0 · Endoscopy 2023; 55(S 01): E876-E877
DOI: 10.1055/a-2109-0300
E-Videos

Endoscopic ultrasound-guided placement of fiducial markers for stereotactic body radiation therapy of pancreatic metastases from renal cell carcinoma

Marcin Polkowski 
1   Department of Gastroenterology, Hepatology and Clinical Oncology, Center of Postgraduate Medical Education, Warsaw, Poland
2   Department of Oncological Gastroenterology, The Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
,
Konrad Pawlewicz
3   Department of Radiotherapy, The Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
,
Krzysztof Skoczylas
1   Department of Gastroenterology, Hepatology and Clinical Oncology, Center of Postgraduate Medical Education, Warsaw, Poland
2   Department of Oncological Gastroenterology, The Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
,
Ewa Wrońska
1   Department of Gastroenterology, Hepatology and Clinical Oncology, Center of Postgraduate Medical Education, Warsaw, Poland
2   Department of Oncological Gastroenterology, The Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
,
Małgorzata Lenarcik
1   Department of Gastroenterology, Hepatology and Clinical Oncology, Center of Postgraduate Medical Education, Warsaw, Poland
4   Department of Pathology and Laboratory Medicine, The Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
,
Jarosław Reguła 
1   Department of Gastroenterology, Hepatology and Clinical Oncology, Center of Postgraduate Medical Education, Warsaw, Poland
2   Department of Oncological Gastroenterology, The Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Isolated pancreatic metastases from renal cell carcinoma (RCC) have traditionally been treated with surgery or systemic therapy [1]. More recently, focal therapies such as endoscopic ultrasound (EUS)-guided radiofrequency ablation or stereotactic body radiation therapy (SBRT) have been reported in selected patients [2] [3] [4]. SBRT uses precision technology to accurately deliver high doses of radiation in a few treatment fractions to the tumor volume, while sparing the surrounding healthy tissues. Many SBRT protocols require the placement of fiducial markers in or near the tumor to facilitate accurate targeting [4] [5]. Here we report EUS-guided fiducial placement for SBRT of pancreatic metastases in a 75-year-old woman with a history of left nephrectomy for RCC 20 years previously and a recent finding of two hypervascular pancreatic tumors on computed tomography (CT) scanning.

The procedure started with EUS examination of the entire pancreas, which revealed the two hypoechoic, well-delineated, well-vascularized tumors of 9 × 8 mm and 22 × 21 mm in size, in the pancreatic head and tail, respectively ([Video 1]). Fine-needle biopsy (FNB) of the tumor in the tail was performed to confirm the diagnosis of RCC metastasis. Following FNB, a 0.018-inch platinum fiducial marker (LumiCoil; Boston Scientific) ([Fig. 1]) was backloaded into a 22G needle (EZShot 3 plus; Olympus Europe) through the tip of the needle. After the tumor had been punctured and the needle tip positioned in its center under EUS guidance, the fiducial was deployed by pushing it out of the needle with the needle stylet. The same technique was used to deploy a second fiducial in the pancreatic head tumor ([Fig. 2]). No adverse events were observed. Both fiducials were clearly visible and correctly positioned on imaging used for planning and the delivery of irradiation ([Fig. 3] and [Fig. 4]). On follow-up 1 year later, the pancreatic metastases were stable; however, pulmonary metastases were detected, and systemic treatment was therefore started.

Video 1 Endoscopic ultrasound-guided placement of fiducial markers for stereotactic body radiation therapy of pancreatic metastases from renal cell carcinoma.


Quality:
Zoom Image
Fig. 1 Photograph of the platinum fiducial marker (LumiCoil), which is 10 × 0.46 mm (0.018 inch) in size, can be loaded into a 22G endoscopic ultrasound needle, and coils into a figure eight-like configuration upon deployment.
Zoom Image
Fig. 2 Endoscopic ultrasound (EUS) images showing the fiducial markers, visible as bright echoes (arrows) in the center of pancreatic metastases from renal cell carcinoma, which are seen as hypoechoic tumors in the: a pancreatic tail (22 × 21 mm in size); b pancreatic head (9 × 8 mm in size).
Zoom Image
Fig. 3 Computed tomography image used for radiotherapy planning showing the fiducial marker (encircled in green) implanted in the tumor of the pancreatic tail (encircled in red). Organs at risk (stomach, bowel) are marked in blue.
Zoom Image
Fig. 4 Cone-beam computed tomography (CBCT) image showing the fiducial marker implanted in the tumor of the pancreatic tail (encircled in red). The tumor itself is not visible, because of the low soft tissue contrast resolution of CBCT imaging; the radiopaque marker is essential for target volume localization. CBCT is performed before delivery of each radiation fraction to verify the target position.

Endoscopy_UCTN_Code_TTT_1AS_2AD

Endoscopy E-Videos
https://eref.thieme.de/e-videos

E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/).

This section has its own submission website at https://mc.manuscriptcentral.com/e-videos



Publication History

Article published online:
13 July 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Sellner F, Thalhammer S, Klimpfinger M. Isolated pancreatic metastases of renal cell cancer: Genetics and epigenetics of an unusual tumour entity. Cancers 2022; 14: 1539
    CrossrefPubMedSearch in Google Scholar
  • 2 Chanez B, Caillol F, Ratone J-P. et al. Endoscopic ultrasound-guided radiofrequency ablation as an future alternative to pancreatectomy for pancreatic metastases from renal cell carcinoma: A prospective study. Cancers 2021; 13: 5267
    CrossrefPubMedSearch in Google Scholar
  • 3 Altoos B, Amini A, Yacoub M. et al. Local control rates of metastatic renal cell carcinoma (RCC) to thoracic, abdominal, and soft tissue lesions using stereotactic body radiotherapy (SBRT). Radiat Oncol 2015; 10: 218
    CrossrefPubMedSearch in Google Scholar
  • 4 Chandnani M, Faisal MF, Glissen-Brown J. et al. EUS-guided fiducial placement for pancreatobiliary malignancies: safety, infection risk, and use of peri-procedural antibiotics. Endosc Int Open 2020; 08: E179-E185
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Dietrich C, Carrara S, Rimbas M. et al. EUS-guided placement of fiducial markers for image-guided radiotherapy in gastrointestinal tumors: A critical appraisal. Endosc Ultrasound 2021; 10: 414-423
    CrossrefPubMedSearch in Google Scholar